Press release
Intravenous Immunoglobulin Market Size Estimated to Reach $17.1 Billion by 2026
Intravenous Immunoglobulin Market
Full Report Link @ https://www.industryarc.com/Research/Intravenous-Immunoglobulin-Market-Research-506919
Intravenous Immunoglobulin Market Segment Analysis-By Product Type
The Intravenous Immunoglobulin Market based on the Product Type can be further segmented into Immunoglobulin G (IgG), Immunoglobulin A (IgA), Immunoglobulin M (IgM), Immunoglobulin E (IgE), and Immunoglobulin D (IgD). The Immunoglobulin G (IgG) segment held the largest share in 2020 owing to its ability to control infection of body tissues and to protect the body from infection by binding many kinds of pathogens, such as viruses and fungi.
The rise in the applications of Immunoglobulin G (IgG) for the treatment of hypogammaglobulinemia is driving the growth of the Intravenous Immunoglobulin Market. The Immunoglobulin A (IgA) segment is estimated to be the fastest growing segment with a CAGR of 8.3% over the period 2021-2026. This growth is owing to its ability to inhibit bacterial adhesion to epithelial cells and neutralize both bacterial and virus toxins. Immunoglobulin A (IgA) also acts as the first line of defense in the resistance against infection.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=506919
Report Price: $ 5900 (Single User License)
Intravenous Immunoglobulin Market Segment Analysis-By Application
The Intravenous Immunoglobulin Market based on the Application can be further segmented into Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Inflammatory Myopathies, Guillain-Barre Syndrome, Specific Antibody Deficiency, and Others. The Hypogammaglobulinemia segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 8.4% over the period 2021-2026. This growth is owing to the factors such as the growing prevalence of hypogammaglobulinemia across the world and the rise in the research and development activities by the key players to developed advanced therapies for the treatment of hypogammaglobulinemia.
The rise in the adoption of intravenous immunoglobulins for the treatment of hypogammaglobulinemia is driving the growth of the Intravenous Immunoglobulin Market. The Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) segment held the second largest share in 2020 owing to the factors such as increase in the prevalence of diabetes mellitus and growing awareness among the consumers about the benefits of minimally invasive and user-friendly procedures for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Intravenous Immunoglobulin Market Segment Analysis-By Geography
North America held the largest share with 29% of the overall market in 2020. The growth in this segment can be attributed to the factors such as increase in the demand for immunoglobulin G (IgG) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) and rise in the research and development activities by the key players to developed advanced therapies for the treatment of hypogammaglobulinemia.
The rise in the adoption of glycoproteins for the treatment of various immunodeficiency diseases is driving the growth of the Intravenous Immunoglobulin Market. Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing awareness about the efficiency of intravenous immunoglobulins as a treatment option and the rise in the adoption of advanced technologies pertaining to immunoglobulin production.
Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=506919
Intravenous Immunoglobulin Market Drivers
Rise in the Adoption of Immunoglobulin Treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Intravenous Immunoglobulins are increasingly being used for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) owing to its associated benefits such as minimally invasive and user-friendly treatment options. These glycoproteins act as a critical part of the immune response by specifically binding to particular antigens, which is one of the major factors driving the growth of the Intravenous Immunoglobulin Market.
Increase in the Prevalence of Immunodeficiency Diseases and Bleeding Disorders
With an increase in the prevalence of immunodeficiency diseases and bleeding disorders across the world, there is an increase in the awareness among consumers about the efficiency of intravenous immunoglobulins as a treatment option. The key players are also focusing on developed advanced intravenous immunoglobulins for the treatment of various immunodeficiency diseases, which is further propelling the growth of the Intravenous Immunoglobulin Market.
Intravenous Immunoglobulin Market Challenges
High Cost of Intravenous Immunoglobulin Therapy
The government of several nations and other organizations are increasing their initiatives to enhance awareness among people about immunodeficiency diseases and the efficiency of various intravenous immunoglobulins as a treatment option. However, the high cost of Intravenous Immunoglobulin therapy is one of the major factors that is estimated to reduce the growth of the Intravenous Immunoglobulin Market.
Intravenous Immunoglobulin Market Competitive Landscape
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Intravenous Immunoglobulin Market. Key companies of this market include Baxter International Inc, Takeda Pharmaceuticals, Bayer Healthcare, AscellaHealth, Kedrion Biopharma, Grifols, Biotest AG, Octapharma AG, LFB group, and Kedrion Biopharma Inc among others.
Partnerships/Product Launches
In November 2020, AscellaHealth has launched its Intravenous Immunoglobulin (IVIG) Medication Therapy to support the aim of the Immune Deficiency Foundation (IDF) and to enhance patient care and cost management approaches.
In June 2020, Grifols has launched its hyperimmune immunoglobulin for the treatment of infections that are applied to healthcare emergencies like the Ebola outbreak and to prevent infections in cases of accidental exposure to infectious agents associated with autoimmune diseases.
In April 2020, Kedrion Biopharma has entered into a partnership with Kamada for the Development, and Distribution of Intravenous Immunoglobulin to make a significant impact for patients in need during the pandemic.
Key Takeaways
Geographically, North America Intravenous Immunoglobulin Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of glycoproteins for the treatment of various immunodeficiency diseases.
The rise in the applications of Immunoglobulin G (IgG) for the treatment of hypogammaglobulinemia is driving the Immunoglobulin G (IgG) segment. However, the high cost of intravenous immunoglobulin therapy is one of the major factors that is said to reduce the growth of the Intravenous Immunoglobulin Market.
Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Intravenous Immunoglobulin Market report.
Related Reports :
A. Injectable Drug Delivery Market
https://www.industryarc.com/Report/1255/injectable-drug-delivery-market-analysis.html
B. Monoclonal Antibodies Market
https://www.industryarc.com/Report/16114/monoclonal-antibodies-market.html
For more Lifesciences and Healthcare Market reports @ https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html
Venkat Reddy
Sales Director
Email: venkat@industryarc.com
Website: https://www.industryarc.com
Phone: (+1) 970-236-3677
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market Size Estimated to Reach $17.1 Billion by 2026 here
News-ID: 2309579 • Views: …
More Releases from IndustryARC
Professional Diagnostics Market Size to Grow at a CAGR of 6.3% During the Foreca …
Professional Diagnostics Market size in 2020 is estimated to be $45 billion, growing at a CAGR of 6.3% during the forecast period 2021-2026. Professional diagnostic is the diagnostic method which are used for faster detection of various diseases such as tuberculosis, cancer, malaria, and others. The main purpose of professional diagnostics is to diagnose or monitor disease in early condition so that treatment can be started so that this diagnostic…
Body Dryer Market Size to Grow at a CAGR of 6.0% During the Forecast Period 2021 …
Body Dryer Market size was valued at $2,978 million in 2020 and is anticipated to reach $5,143 million by the end of 2026 growing at a CAGR of 6.0% during the forecast period 2021-2026. The Body Dryer industry growth rate is attributed to the rising need to reduce medication errors and development of automated systems with improved features and is likely to new opportunities. Body dryers are type of air…
India P2P Lending Market Size Forecast to Reach $10.5 Billion by 2026
The India P2P lending Market size is forecast to reach $10.5 billion by 2026, after growing at a CAGR of 21.6% during the forecast period 2021-2026. The Peer to Peer Lending Market growth is attributed to increasing transparency in P2P lending with technologies such as block chain and smart contracts being incorporated into lending platforms. The Indian Government’s enthusiastic promotion of cashless technologies has also managed to restructure the financial…
Cloud Relational Database Market Forecast to Reach $18.8 Billion by 2026
Cloud Relational Database Market is forecast to reach $18.8 billion by 2026, after growing at a CAGR of 38.4% during 2021-2026. With rise in the adoption of IoT technologies and the usage of cloud database for computing in various organizations for different applications is analyzed to boost the Cloud Relational Database Market. Moreover, the cloud databases provide the customers with improved performance, service resilience and so on, thereby enhancing the…
More Releases for Immunoglobulin
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements …
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate?
There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South…
Boosting Immunity: Innovations in Subcutaneous Immunoglobulin (SCIG)
The Business Research Company recently released a comprehensive report on the Global Subcutaneous Immunoglobulin (SCIG) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,…
Korea Intravenous Immunoglobulin Market Analysis to 2031
Intravenous Immunoglobulin Market Outlook 2031
The global intravenous immunoglobulin market was valued at US$ 11.2 Bn in 2021
It is estimated to grow at a CAGR of 7.3% from 2022 to 2031
The global intravenous immunoglobulin market is expected to reach value of US$ 20.5 Bn by the end of 2031
Get Sample Copy of the Report@
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930
Overview of Intravenous Immunoglobulin Market
Immunoglobulins are highly purified, sterile-specific medical therapy solutions containing gamma globulin G (IgG) in a concentration of 95% or more. These are manufactured from a highly…
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of…
